Skip to main content

16-06-2017 | Prostate cancer | Interview | Video

STAMPEDE trial changes standard of care


Presenting author Nicholas James discusses the STAMPEDE trial results supporting the upfront use of abiraterone acetate in advanced prostate cancer patients beginning long-term androgen deprivation therapy.

2022 ASCO Annual Meeting coverage

Access the latest news and expert insight from the 2022 ASCO Annual Meeting

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.